[Risk factors and control measures in measles outbreaks in countries of the Region of the Americas, 2017-2023Fatores de risco e medidas de controle em surtos de sarampo em países da Região das Américas, 2017-2023].

IF 2 4区 医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Revista Panamericana De Salud Publica-pan American Journal of Public Health Pub Date : 2024-12-16 eCollection Date: 2024-01-01 DOI:10.26633/RPSP.2024.105
Desirée Pastor, Pamela Bravo-Alcántara, Regina Durón, Carmelita P Tirso, Claudia Ortiz, Gloria Rey-Benito
{"title":"[Risk factors and control measures in measles outbreaks in countries of the Region of the Americas, 2017-2023Fatores de risco e medidas de controle em surtos de sarampo em países da Região das Américas, 2017-2023].","authors":"Desirée Pastor, Pamela Bravo-Alcántara, Regina Durón, Carmelita P Tirso, Claudia Ortiz, Gloria Rey-Benito","doi":"10.26633/RPSP.2024.105","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To document and compare risk factors and control measures for the largest measles outbreaks in the post-elimination era in the Region of the Americas.</p><p><strong>Methods: </strong>Description of risk factors such as vaccination coverage, notification rate of suspected cases, measles incidence, and a summary of control measures for major measles outbreaks in six countries from 2017 to 2023. The analysis also includes a review of outbreak characteristics (time, place, and person).</p><p><strong>Results: </strong>Between 2017 and 2023, 19 countries in the Americas reported a total of 50 082 cases and 121 deaths from measles. Of these cases, 49 738 (99.3%) were reported in six countries: Argentina, Brazil, Colombia, Mexico, the United States of America, and Venezuela. In two of these six countries, endemic transmission was reestablished due to the presence of risk factors that could not be managed with the control measures initially established. Between 2017 and 2019, the predominant genotypes and lineages were the MVi/Hulu Langat.MYS/26.11 (D8) lineage and the Gir Somnath.IND/42.16 (D8) lineage.</p><p><strong>Conclusions: </strong>Countries that had better coverage with two doses of measles, rubella, and mumps vaccine, optimal notification rates, and incidence rates of less than 5 cases per million population responded better and faster to measles outbreaks and were able to interrupt virus transmission before 12 months of circulation.</p>","PeriodicalId":21264,"journal":{"name":"Revista Panamericana De Salud Publica-pan American Journal of Public Health","volume":"48 ","pages":"e105"},"PeriodicalIF":2.0000,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11648204/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Panamericana De Salud Publica-pan American Journal of Public Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.26633/RPSP.2024.105","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To document and compare risk factors and control measures for the largest measles outbreaks in the post-elimination era in the Region of the Americas.

Methods: Description of risk factors such as vaccination coverage, notification rate of suspected cases, measles incidence, and a summary of control measures for major measles outbreaks in six countries from 2017 to 2023. The analysis also includes a review of outbreak characteristics (time, place, and person).

Results: Between 2017 and 2023, 19 countries in the Americas reported a total of 50 082 cases and 121 deaths from measles. Of these cases, 49 738 (99.3%) were reported in six countries: Argentina, Brazil, Colombia, Mexico, the United States of America, and Venezuela. In two of these six countries, endemic transmission was reestablished due to the presence of risk factors that could not be managed with the control measures initially established. Between 2017 and 2019, the predominant genotypes and lineages were the MVi/Hulu Langat.MYS/26.11 (D8) lineage and the Gir Somnath.IND/42.16 (D8) lineage.

Conclusions: Countries that had better coverage with two doses of measles, rubella, and mumps vaccine, optimal notification rates, and incidence rates of less than 5 cases per million population responded better and faster to measles outbreaks and were able to interrupt virus transmission before 12 months of circulation.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[2017-2023年美洲地区国家爆发麻疹的风险因素和控制措施2017-2023年美洲地区国家爆发麻疹的风险因素和控制措施]。
目的:记录和比较美洲区域消除麻疹后最大规模暴发的危险因素和控制措施。方法:对2017 - 2023年6个国家麻疹疫苗接种率、疑似病例通报率、麻疹发病率等危险因素进行描述,总结6个国家重大麻疹疫情防控措施。分析还包括对爆发特征(时间、地点和人员)的回顾。结果:2017年至2023年,美洲19个国家共报告了50,082例麻疹病例,121例死亡。在这些病例中,阿根廷、巴西、哥伦比亚、墨西哥、美利坚合众国和委内瑞拉这六个国家报告了49 738例(99.3%)。在这6个国家中的2个,由于存在无法用最初确定的控制措施加以控制的风险因素,重新确立了地方性传播。2017 - 2019年,主要基因型和谱系为MVi/Hulu Langat.MYS/26.11 (D8)和Gir Somnath.IND/42.16 (D8)。结论:麻疹、风疹和腮腺炎两剂疫苗覆盖率较高,通报率最佳,发病率低于每百万人口5例的国家对麻疹疫情的反应更好、更快,能够在传播12个月之前阻断病毒传播。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.10
自引率
3.80%
发文量
222
审稿时长
20 weeks
期刊最新文献
[Analysis of the surveillance system for adverse events following Immunization (AEFI) related to COVID-19 vaccines in Colombia, 2021-2023Análise do sistema de vigilância de ESAVI por vacinas contra a COVID-19 na Colômbia, 2021-2023]. [Knowledge, practices, and human seroprevalence of brucellosis in the central dairy-producing area of Cochabamba, BoliviaConhecimentos, práticas e soroprevalência humana de brucelose na área central de produção de laticínios de Cochabamba, Bolívia]. Point prevalence survey of antibiotics in a pediatric tertiary hospital in the Republic of Panama. [Controlling cystic echinococcosis: outlook in the 21st centuryControle da equinococose/hidatidose cística: perspectivas no século XXI]. [Pharmacovigilance of COVID-19 Vaccines in Brazil: Actions Taken, Lessons Learned, and Next StepsFarmacovigilancia de las vacunas contra la COVID-19 en Brasil: medidas adoptadas, enseñanzas extraídas y próximos pasos].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1